-

PRCT ALERT: Hagens Berman Reminds PROCEPT BioRobotics (PRCT) Investors of the September 22, 2026 Lead Plaintiff Deadline

SAN FRANCISCO--(BUSINESS WIRE)--Hagens Berman reminds investors in PROCEPT (NASDAQ: PRCT) of the September 22, 2026 lead plaintiff deadline in an ongoing securities class action.

“We’re focused on whether PROCEPT deceptively pulled-in sales from future quarters,” said Reed Kathrein, a Hagens Berman partner.

Share

The firm encourages investors who suffered substantial losses to submit your losses now.

Class Period: Feb. 28, 2024 – Feb. 25, 2026
Visit: www.hbsslaw.com/prct
Contact the Firm Now: PRCT@hbsslaw.com

844-916-0895

Video: youtu.be/N5u0rLr0QmA

What does the PRCT Class Action allege?

The lawsuit alleges that defendants concealed an extensive, undisclosed bulk-order discount program. This program allegedly inflated sales by incentivizing customers to purchase handpieces far exceeding actual procedure demand.

The truth emerged through a series of disclosures, culminating on February 25, 2026, when PROCEPT reported disappointing Q4 results, revealed a massive inventory overhang, and announced the elimination of the discount program, causing PRCT stock to drop.

What is Hagens Berman investigating?

“We’re focused on whether PROCEPT deceptively pulled-in sales from future quarters,” said Reed Kathrein, a Hagens Berman partner.

What can PRCT Investors Do?

If you invested in PROCEPT during the Class Period and suffered losses, you have until September 22, 2026, to ask the court to appoint you as lead plaintiff. Contact the firm now to discuss your rights.

Whistleblowers: Persons with non-public information regarding PROCEPT should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email PRCT@hbsslaw.com.

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.

Contacts

Hagens Berman, Reed Kathrein, 715 Hearst Avenue, Suite 300, Berkeley, CA 94710, 844-916-0895, PRCT@hbsslaw.com

Hagens Berman

NASDAQ:PRCT

Release Summary
Hagens Berman is investigating claims in a class action complaint filed on behalf of investors in PROCEPT BioRobotics (PRCT) against the Company.
Release Versions
$Cashtags

Contacts

Hagens Berman, Reed Kathrein, 715 Hearst Avenue, Suite 300, Berkeley, CA 94710, 844-916-0895, PRCT@hbsslaw.com

Social Media Profiles
More News From Hagens Berman

WIX ALERT: Hagens Berman Reminds Wix.com Ltd. (NASDAQ: WIX) Investors of September 22, 2026 Lead Plaintiff Deadline

SAN FRANCISCO--(BUSINESS WIRE)--Hagens Berman is investigating claims in a class action complaint filed on behalf of investors in Wix.com Ltd. (NASDAQ: WIX) against the Company....

CCOI 5-DAY DEADLINE ALERT: Hagens Berman Alerts CCOI Investors to September 21, 2026 Lead Plaintiff Deadline in Securities Class Action

SAN FRANCISCO--(BUSINESS WIRE)--Hagens Berman is investigating claims in a class action complaint filed on behalf of investors in Cogent Communications (CCOI) against the Company....

Hagens Berman Files Antitrust Class-Action Lawsuit Against Verisign and ICANN Alleging Billions of Dollars in Illicit Gains from Website Domain Owners

LOS ANGELES--(BUSINESS WIRE)--Hagens Berman filed an antitrust class-action lawsuit accusing Verisign and ICANN of an illegal monopoly, charging excessive fees for .com domains....
Back to Newsroom